0001554289-16-000007.txt : 20161031 0001554289-16-000007.hdr.sgml : 20161031 20161031140154 ACCESSION NUMBER: 0001554289-16-000007 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161031 DATE AS OF CHANGE: 20161031 EFFECTIVENESS DATE: 20161031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CURE PHARMACEUTICAL Corp CENTRAL INDEX KEY: 0001554289 IRS NUMBER: 452717791 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-273395 FILM NUMBER: 161961105 BUSINESS ADDRESS: STREET 1: 1620 BEACON PLACE CITY: OXNARD STATE: CA ZIP: 93033 BUSINESS PHONE: 805 824 0410 MAIL ADDRESS: STREET 1: 1620 BEACON PLACE CITY: OXNARD STATE: CA ZIP: 93033 D/A 1 primary_doc.xml X0707 D/A LIVE 0001554289 CURE PHARMACEUTICAL Corp 1620 BEACON PLACE OXNARD CA CALIFORNIA 93033 805 824 0410 CALIFORNIA None None Corporation true Rob Davidson 1620 Beacon Place Oxnard CA CALIFORNIA 93033 Executive Officer Director Chief Executive Officer Ed Maliski 1620 Beacon Place Oxnard CA CALIFORNIA 93033 Director Vic Branstetter 1620 Beacon Place Oxnard CA CALIFORNIA 93033 Director Wayne Nasby 1620 Beacon Place Oxnard CA CALIFORNIA 93033 Director Ian Sephton 1620 Beacon Place Oxnard CA CALIFORNIA 93033 Director Mark Udell 1620 Beacon Place Oxnard CA CALIFORNIA 93033 Executive Officer Chief Financial Officer Pharmaceuticals Decline to Disclose 06b true 0001554289-16-000002 2011-07-25 false true true true Convertible Promissory Note and Option to Purchase Common Stock false 0 2000000 2000000 0 false 1 0 0 0 false CURE PHARMACEUTICAL Corp Mark Udell Mark Udell Chief Financial Officer 2016-10-31